Participant flow15

How many started, completed or left each group, period by period.

1 to 15 of 15

Period	Milestone	Group	Participants
Overall Study	STARTED	Cohort 1 Eleclazine 3 mg	48
Overall Study	STARTED	Cohort 1 Placebo	46
Overall Study	STARTED	Cohort 2 Eleclazine 3 mg	70
Overall Study	STARTED	Cohort 2 Eleclazine 6 mg	74
Overall Study	STARTED	Cohort 2 Placebo	75
Overall Study	COMPLETED	Cohort 1 Eleclazine 3 mg	30
Overall Study	COMPLETED	Cohort 1 Placebo	35
Overall Study	COMPLETED	Cohort 2 Eleclazine 3 mg	54
Overall Study	COMPLETED	Cohort 2 Eleclazine 6 mg	57
Overall Study	COMPLETED	Cohort 2 Placebo	63
Overall Study	NOT COMPLETED	Cohort 1 Eleclazine 3 mg	18
Overall Study	NOT COMPLETED	Cohort 1 Placebo	11
Overall Study	NOT COMPLETED	Cohort 2 Eleclazine 3 mg	16
Overall Study	NOT COMPLETED	Cohort 2 Eleclazine 6 mg	17
Overall Study	NOT COMPLETED	Cohort 2 Placebo	12

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT02104583/flow